These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38645474)

  • 41. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study.
    Juhl P; Vinderslev Iversen L; Karlsmark T; Asser Karsdal M; Bay-Jensen AC; Mogensen M; Siebuhr AS
    Biomarkers; 2019 Jun; 24(4):373-378. PubMed ID: 30821519
    [No Abstract]   [Full Text] [Related]  

  • 42. Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.
    Ledoult E; Launay D; Béhal H; Mouthon L; Pugnet G; Lega JC; Agard C; Allanore Y; Jego P; Fauchais AL; Harlé JR; Berthier S; Aouba A; Mekinian A; Diot E; Truchetet ME; Boulon C; Duhamel A; Hachulla E; Sobanski V;
    Arthritis Res Ther; 2020 Feb; 22(1):30. PubMed ID: 32070422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time.
    Skaug B; Lyons MA; Swindell WR; Salazar GA; Wu M; Tran TM; Charles J; Vershel CP; Mayes MD; Assassi S
    Ann Rheum Dis; 2022 Apr; 81(4):516-523. PubMed ID: 34937693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
    Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.
    Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Miura S; Toyama T; Yoshizaki A; Sumida H; Asano Y; Oba K; Sato S
    Arthritis Res Ther; 2019 May; 21(1):129. PubMed ID: 31138286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study.
    Foocharoen C; Thinkhamrop B; Mahakkanukrauh A; Suwannaroj S; Netwijitpan S; Sripavatakul K; Chuealee W; Boottam B; Towiwat P; Seubmee P; Daungkum K; Kongpan D; Mangkala J; Nanagara R
    J Med Assoc Thai; 2015 Nov; 98(11):1082-8. PubMed ID: 26817178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
    Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
    Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.
    Wu W; Jordan S; Graf N; de Oliveira Pena J; Curram J; Allanore Y; Matucci-Cerinic M; Pope JE; Denton CP; Khanna D; Distler O;
    Ann Rheum Dis; 2019 May; 78(5):648-656. PubMed ID: 30852552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study.
    Foocharoen C; Peansukwech U; Mahakkanukrauh A; Suwannaroj S; Pongkulkiat P; Khamphiw P; Nanagara R
    Int J Rheum Dis; 2020 Jul; 23(7):945-957. PubMed ID: 32420701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.
    Herrick AL; Peytrignet S; Lunt M; Pan X; Hesselstrand R; Mouthon L; Silman AJ; Dinsdale G; Brown E; Czirják L; Distler JHW; Distler O; Fligelstone K; Gregory WJ; Ochiel R; Vonk MC; Ancuţa C; Ong VH; Farge D; Hudson M; Matucci-Cerinic M; Balbir-Gurman A; Midtvedt Ø; Jobanputra P; Jordan AC; Stevens W; Moinzadeh P; Hall FC; Agard C; Anderson ME; Diot E; Madhok R; Akil M; Buch MH; Chung L; Damjanov NS; Gunawardena H; Lanyon P; Ahmad Y; Chakravarty K; Jacobsen S; MacGregor AJ; McHugh N; Müller-Ladner U; Riemekasten G; Becker M; Roddy J; Carreira PE; Fauchais AL; Hachulla E; Hamilton J; İnanç M; McLaren JS; van Laar JM; Pathare S; Proudman SM; Rudin A; Sahhar J; Coppere B; Serratrice C; Sheeran T; Veale DJ; Grange C; Trad GS; Denton CP
    Ann Rheum Dis; 2018 Apr; 77(4):563-570. PubMed ID: 29306872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis.
    Leodori G; Pellicano C; Basile V; Colalillo A; Navarini L; Gigante A; Gulli F; Marino M; Basile U; Rosato E
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do We Have Good Activity Indices in Systemic Sclerosis?
    Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
    Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis.
    Wangkaew S; Sivasomboon C; Leungwatthananon W; Kasitanon N; Louthrenoo W
    Int J Rheum Dis; 2018 Jan; 21(1):240-248. PubMed ID: 27456855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis.
    Hinchcliff M; Huang CC; Wood TA; Matthew Mahoney J; Martyanov V; Bhattacharyya S; Tamaki Z; Lee J; Carns M; Podlusky S; Sirajuddin A; Shah SJ; Chang RW; Lafyatis R; Varga J; Whitfield ML
    J Invest Dermatol; 2013 Aug; 133(8):1979-89. PubMed ID: 23677167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort.
    Hughes M; Huang S; Alegre-Sancho JJ; Carreira PE; Engelhart M; Hachulla E; Henes J; Kerzberg E; Pozzi MR; Riemekasten G; Smith V; Szücs G; Vanthuyne M; Zanatta E; Distler O; Gabrielli AG; Hoffmann-Vold AM; Steen VD; Khanna D;
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI54-SI63. PubMed ID: 35731139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of modified Rodnan skin score and esophageal manometry in systemic sclerosis: a study correlating severity of skin and esophageal involvement by objective measures.
    Arif T; Adil M; Singh Sodhi J; Hassan I
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Dec; 27(4):169-173. PubMed ID: 30564828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.
    Rice LM; Padilla CM; McLaughlin SR; Mathes A; Ziemek J; Goummih S; Nakerakanti S; York M; Farina G; Whitfield ML; Spiera RF; Christmann RB; Gordon JK; Weinberg J; Simms RW; Lafyatis R
    J Clin Invest; 2015 Jul; 125(7):2795-807. PubMed ID: 26098215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.